Clinical Trials Directory

Trials / Completed

CompletedNCT02785744

Genzyme Osteopenia/Osteoporosis Study

Prevalence of Gaucher Among Patients With Osteopenia/Osteoporosis

Status
Completed
Phase
Study type
Observational
Enrollment
76 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Gaucher disease is a most common genetic metabolic disease characterized by low platelet number, liver and spleen enlargement and various forms of bone diseases including low bone mineral density leading to brittle bones. Various treatment options are now available for this disease. The purpose of this research study is to determine the prevalence of Gaucher disease in patients with low bone mineral density as observed by DEXA scan, which is a form of X-Ray of the bone.

Detailed description

Gaucher disease is a potential secondary cause of low bone mineral density and it is prevalent among patients with low BMD. This cross sectional design study will measure point prevalence of Gaucher disease in patients with low bone mineral density (BMD).

Conditions

Interventions

TypeNameDescription
OTHERGaucher disease DNA mutation analysis

Timeline

Start date
2016-04-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2016-05-30
Last updated
2021-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02785744. Inclusion in this directory is not an endorsement.

Genzyme Osteopenia/Osteoporosis Study (NCT02785744) · Clinical Trials Directory